Isoniazid drug and food interactions

American Journal of the Medical Sciences

Volumn 317, Issue 5, 1999, Pages 304-311

  Self, Timothy H ^a   Chrisman, Cary R ^b   Baciewicz, Anne M ^c   Bronze, Michael S ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Stadtlanders   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Drug interactions; Food interactions; Isoniazid

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING); BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; DIMETHYLNITROSAMINE DEMETHYLASE; ISONIAZID; PARACETAMOL; PHENYTOIN; THEOPHYLLINE; VITAMIN D; WARFARIN;

AREA UNDER THE CURVE; DRUG BIOAVAILABILITY; ENZYME INDUCTION; ENZYME INHIBITION; FOOD DRUG INTERACTION; HUMAN; LIVER TOXICITY; METABOLIC INHIBITION; REVIEW;

EID: 0033505685     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9629(15)40533-6     Document Type: Review

References (76)

1. Bass JB Jr, Farer LS, Hopewell PC, et al. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. Am J Respir Crit Care Med 1994; 149:1359-74.
2. Maukkassah SF, Bidlack WF, Yang WCT. Mechanism of the inhibitory action of isoniazid on microsomal drug metabolism. Biochem Pharmacol 1981;30:1651-8.
3. Weber WW, Hein DW. Clinical pharmacokinetics of isoniazid. Clin Pharmacokin 1979;401-22.
4. Hauser MJ, Baier H. Interactions of isoniazid with foods. Drug Intell Clin Pharm 1982;16:617-8.
5. Zand R, Nelson SD, Slattery JT, et al. Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans. Clin Pharmacol Ther 1993;54: 142-9.
6. O'Shea D, Kim RB, Wilkinson GR. Modulation of CYP2E1 activity by isoniazid in rapid and slow N-acetylators. Br J Clin Pharmacol 1997;43:99-103.
7. Chien JY, Thummel KE, Slattery JT. Pharmacokinetic consequences of induction of CYP2E1 by ligand stabilization. Drug Metab Dispos 1997;25:1165-75.
8. Murphy R, Swartz R, Watkins PB. Severe acetaminophen toxicity in a patient receiving isoniazid. Ann Intern Med 1990;113:799-800.
9. Murray FJ. Outbreak of unexpected reactions among epileptics taking isoniazid. Am Rev Respir Dis 1962;86:729-32.
10. Kutt H, Winters W, McDowell FJ. Depression of parahydroxylation of diphenylhydantoin by antituberculosis chemotherapy. Neurology 1966;16:594-602.
11. Kutt H, Verebely K, McDowell F. Inhibition of diphenylhydantoin metabolism in rats and in rat liver microsomes by antitubercular drugs. Neurology 1968;18:706-10.
12. Kutt H, Brennan R, Dehejia H, et al. Diphenylhydantoin intoxication. Am Rev Respir Dis. 1970;101:377-84.
13. Miller RR, Porter J, Greenblatt DJ. Clinical importance of the interaction of phenytoin and isoniazid. Chest 1979;75: 356-8.
14. Engel J, Cruz ME, Shapiro B. Phenytoin encephalopathy [Letter to the editor]. Lancet 1971;2:824-5.
15. Johnson J. Epanutin and isoniazid interaction [Letter to the editor]. Br Med J 1975;1:152.
16. Sandyk R. Phenytoin toxicity induced by antituberculosis drugs. S Afr Med J 1982;61:382.
17. Geering JM, Ruch W, Dettli L. Diphenylhydantoin intoxikation durch diphenylhydantoin-isoniazid interaktion. Schweiz Med Wochenschr 1974;104:1224-8.
18. Beauvais P, Mercier D, Hanoteau J, et al. Intoxication a la diphenylhydantoine induite parl'isoniazide. Arch Fr Pediatr 1973;30:541-6.
19. Boudin G, Pepin B, Decroix G, et al. Intoxication par la dephenyhydantoine declenchee par un traitment antituberculeux. Ann Med Interne 1971;122:855-60.
20. Manigand G, Thieblot PH, Deparis M. Accidents de la dephenylhydantoine induits par les traitments antituberculeux. Presse Med 1971;79:815-6.
21. Walubo A, Aboo A. Phenytoin toxicity due to concomitant antituberculosis therapy. S Afr Med J 1995;85:1175-76.
22. Johnson J, Freeman HL. Death due to isoniazid and phenytoin [Letter to the editor]. Br J Psychiatry 1976;129:511.
23. Yew WW, Lau KS, Ling MH. Phenytoin toxicity in a patient with isoniazid-induced hepatitis. Tubercle 1991;72:309-10.
24. Thulasimnay M, Kela AK. Improvement of psychomotor epilepsy due to interaction of phenytoin-isoniazid. Tubercle 1984;65:229-30.
25. Witmer DR, Ritschel WA. Phenytoin-isoniazid interaction: a kinetic approach to management. Drug Intell Clin Pharm 1984;18:483-6.
26. Kay L, Kampmann JP, Svendsen TL, et al. Influence of rifampicin and isoniazid on the kinetics of phenytoin. Br J Clin Pharmacol 1985;20:323-6.
27. Valsalan VC, Cooper GL. Carbamazepine intoxication caused by interaction with isoniazid. Br Med J (Clin Res Ed) 1982;285:261-2.
28. Wright JM, Stokes EF, Sweeney VP. Isoniazid-induced carbamazepine toxicity and vice versa. N Engl J Med 1982; 307:1325-7.
29. Block SH. Carbamazepine-isoniazid interaction. Pediatrics 1982;69:494-5.
30. Dold U, Reichenmiller JE. Akute leberzellschadigung beim menschen durch gleichzeitige gabe von isoikontinsaurehydrazid und aniepileptika. Med Welt 1969;1:48-54.
31. Fleenor ME, Harden JW, Curtis G. Interaction between carbamazepine and antituberculosis agents [Letter to the editor]. Chest 1991;99:1554.
32. Garcia B, Zaborras E, Areas V, et al. Interaction between isoniazid and carbamazepine potentiated by cimetidine [Letter to the editor]. Ann Pharmacotherapy 1992;26:842.
33. Hoglund P, Nillson LG, Paulsen O. Interaction between isoniazid and theophylline. Eur J Respir Dis 1987;70:110-6.
34. Samigun M, Santoso B. Lowering of theophylline clearance by isoniazid in slow and rapid acetylators. Br J Clin Pharmacol 1990;29:570-3.
35. Torrent J, Izquierdo I, Cabezas R, et al. Theophylline-isoniazid interaction. DICP 1989;23:143-5.
36. Thompson JR, Burckart GJ, Self TH, et al. Isoniazid-induced alterations of theophylline pharmacokinetics. Curr Ther Res 1982;32:921-25.
37. Thompson JR, Self TH. Theophylline and isoniazid [Letter to the editor]. Br J Clin Pharmacol 1990;30:909.
38. Vozeh S, Powell JR, Cupit GC, et al. Influence of allopurinol on theophylline disposition adults. Clin Pharmacol Ther 1980;27:194-7.
39. Rosenthal AR, Self TH, Baker ED, et al. Interaction of isoniazid and warfarin. JAMA 1977;238:2177.
40. Eade NR, McLeod PJ, MacLeod SM. Potentiation of bishydroxycoumarin in dogs by isoniazid and p-aminosalicylic acid. Am Rev Respir Dis 1971;103:792-9.
41. Kiblawi SS, Jay SJ, Nils U, et al. Influence of isoniazid on the anticoagulant effect of warfarin. Clin Ther 1979;2:235-9.
42. Hurwitz A, Sclozman DL. Effects of antacids on gastrointestinal absorption of isoniazid in rat and man. Am Rev Respir Dis 1974;109:41-47.
43. 2 blockers and isoniazid. Eur J Respir Dis 1986; 68:286-90.
44. Gallicano K, Sahai J, Zaror-Behrens G, et al. Effect of antacids in didanosine tablet on bioavailability of isoniazid. Antimicrob Agents Chemother 1994;38:894-97.
45. Moulding T, Redeker A, Kamel G. Acetaminophen, isoniazid, and hepatic toxicity. Ann Intern Med 1991;114:431.
46. Crippin J. Acetaminophen hepatotoxicity: potentiation by isoniazid. Am J Gastroenterol 1993;88:590-2.
47. Nolan C, Sandblom R, Thummel K, et al. Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis. Chest 1994;105:408-11.
48. Epstein MM, Nelson SD, Slattery JT, et al. Inhibition of the metabolism of paracetamol by isoniazid. Br J Clin Pharmacol 1991;31:139-42.
49. Chien JY, Peter RM, Nolan CM, et al. Influence of polymorphic N-acetyl transferase on the inhibition and induction acetaminophen bioactivation with long term isoniazid. Clin Pharmacol Ther 1997;61:24-34.
50. Raucy J, Lasker J, Lieber C, et al. Acetaminophen activation by human liver cytochromes P4502E1 and P4501A2. Arch Biochem Biophys 1989;271:270-83.
51. Mazze R, Woodruff R, Heerdt R. Isoniazid-induced enflurane defluorination in humans. Anesthesiology 1982;57:5-8.
52. Gauntlett I, Koblin D, Fahey M, et al. Metabolism of isoflurane in patients receiving isoniazid. Anesth Analg 1989; 69:245-9.
53. Ochs HR, Greenblatt DJ, Roberts GM, et al. Diazepam interaction with antituberculosis drugs. Clin Pharmacol Ther 1981;29:671-8.
54. Ochs HR, Greenblatt DJ, Knuchel M. Differential effect of isoniazid on triazolam oxidation and oxazepam conjugation. Br J Clin Pharmacol 1983;16:743-6.
55. Strayhorn VA, Baciewicz AM, Self TH. Update on rifampin drug interactions, III. Arch Intern Med 1997;157: 2453-8.
56. Brodie MJ, Boobis AR, Hillyard CJ, et al. Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity. Clin Pharmacol Ther 1981;30:363-7.
57. Brodie MJ, Boobis AR, Hillyard CJ, et al. Effect of rifampicin and isoniazid on vitamin D metabolism. Clin Pharmacol Ther 1982;32:525-30.
58. Williams SE, Wardman AG, Taylor GA, et al. Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism. Tubercle 1985;66:49-54.
59. Kovacs CS, Jones G, Yendt ER. Primary hyperparathyroidism masked by antituberculous therapy-induced vitamin D deficiency. Clin Endocrinol 1994;41:831-6.
60. Dockweiler U. Isoniazid-induced valproic acid toxicity, or vice versa [Letter to the editor]. Lancet 1987;2:152.
61. Jonville AP, Gauchez AS, Autret E, et al. Interaction between isoniazid and valproate: a case of valproate overdosage. Eur J Clin Pharmacol 1991;40:197-8.
62. Engelhard D, Stutman HR, Marks MI. Interaction of ketoconazole with rifampin and isoniazid. N Engl J Med 1984;311:1681-3.
63. Abadie-Kemmerly S, Parkey GA, Dalovisio JR. Failure of ketoconazole treatment of Blastomyces dermatitidis due to interaction of isoniazid and rifampin. Ann Intern Med 1988; 109:844-5.
64. Judd FK, Mijch AM, Cockram A, et al. Isoniazid and antidepressants: is there cause for concern? Int Clin Psychopharmacol 1994;9:123-5.
65. Malek-Ahmadi P, Chavez M, Contreras SA. Coadministration of isoniazid and antidepressant drugs [Letter to the editor]. J Clin Psychiatry 1996;57:550.
66. Mattila MJ, Takki S, Jussila J. Effect of sodium sulphate and castor oil on drug absorption from the human intestine. Ann Clin Res 1974;6:19-24.
67. Sahai J, Gallicano K, Swick L, et al. Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection. Ann Intern Med 1997;127:289-93.
68. Leimenstall G, Schlegelberger T, Fulde R, et al. Interaction of cyclosporin and ethambutol-isoniazid. Deutsche Med Wochenschr 1988;31:514-5.
69. Takeda M, Nishinuma K, Yamashita S, et al. Serum haloperidol levels of schizophrenics receiving treatment for tuberculosis. Clin Neuropharmacol 1986;9:386-7.
70. Baciewicz AM, Self TH. Isoniazid interactions. South Med J 1985;78:714-8.
71. Melander A, Kanielson K, Hanson. A et al. Reduction of isoniazid bioavailability in normal men by concomitant intake of food. Acta Med Scand 1976;200:93-7.
72. Mannisto P, Mantyla R, Klinge R, et al. Influence of various diets on the bioavailability of isoniazid. J Antimicrob Chemother 1982;10:427-34.
73. Smith CK, Durack DT. Isoniazid and reaction to cheese. Ann Intern Med 1978;88:520-1.
74. Senanayake N, Vyravanathan S, Kanagasuriyam S. Cerebrovascular accident after a "skipjack" reaction in a patient taking isoniazid. Br Med J 1978;2:1127-8.
75. O'Sullivan TL. Drug-food interaction with isoniazid resembling anaphylaxis. Ann Pharmacother 1997;31:928-9.
76. Morinaga S, Kawasaki A, Hirata H, et al. Histamine poisoning after ingestion of spoiled raw tuna in a patient taking isoniazid. Intern Med 1997;36:198-200.